Evidence map›Paper›PMID 31792961›Full record

ArticleFEBS letters2020

Capsids of hepatitis B virus e antigen with authentic C termini are stabilized by electrostatic interactions.

Norman R Watts, Ira W Palmer, Elif Eren, Alasdair C Steven, Paul T Wingfield

Abstract read
In one paragraph

Article in FEBS letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Norman R WattsProtein Expression Laboratory, NIAMS, National Institutes of Health, Bethesda, MD, USA.
Ira W PalmerProtein Expression Laboratory, NIAMS, National Institutes of Health, Bethesda, MD, USA.
Elif ErenLaboratory of Structural Biology Research, NIAMS, National Institutes of Health, Bethesda, MD, USA.
Alasdair C StevenLaboratory of Structural Biology Research, NIAMS, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-4104-6497
Paul T WingfieldProtein Expression Laboratory, NIAMS, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-9515-4752

Funding

Structural Biology Of Virus AssemblyZIAAR027002 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI WINGFIELD, PAUL T · 2009 to 2024
$19.2M
Production Of HIV And HIV Related Proteins For Structural StudiesZIAAR041115 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI WINGFIELD, PAUL T · 2009 to 2025
$16.9M
STRUCTURE OF THE HEPATITIS B NUCLEOCAPSID PROTEINZ01AR041117 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI WINGFIELD, PAUL T · 1996 to 2008
$1.4M
Intramural NIH HHS Z01 AR041117Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health ZIA AR027002-41
6 · The paper itself

Abstract

The hepatitis B virus e antigen, an alternative transcript of the core gene, is a secreted protein that maintains viral persistence. The physiological form has extended C termini relative to Cp(-10)149, the construct used in many studies. To examine the role of the C termini, we expressed the constructs Cp(-10)151 and Cp(-10)154, which have additional arginine residues. Both constructs when treated with reductant formed capsids more efficiently than Cp(-10)149. These capsids were also substantially more stable, as measured by thermal denaturation and resistance to urea dissociation. Mutagenesis suggests that electrostatic interactions between the additional arginine residues and glutamate residues on adjacent subunits play a role in the extra stabilization. These findings have implications for the physiological role and biotechnological potential of this protein.

Indexed as

CapsidHepatitis B e AntigensHepatitis B virusMutagenesisProtein DomainsStatic ElectricityHepatitis B e Antigensconformational rearrangemente antigenencapsidationfurin cleavageHBeAghepatitis B virus

Identifiers

PMID31792961
PMCPMC7337981

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.